Mother-infant Bonding in the Brain: a Mindfulness-based Intervention
Postpartum Depression, Postpartum Anxiety, Parental Stress
About this trial
This is an interventional treatment trial for Postpartum Depression focused on measuring Postpartum depression, Postpartum anxiety, Parental stress, Mindfulness, Mindful with your baby, Mother-infant interaction
Eligibility Criteria
Inclusion Criteria: Pregnant women (18+y). First antenatal visit < 12 weeks. Score above cut off on the Edinburgh Postnatal Depression Scale (EPDS), the anxiety subscale of the Symptom Checklist (SCL-90) and/or the Parental Stress Questionnaire (PSQ) at 8-10 weeks postpartum. Dutch-speaking or understanding Dutch. Exclusion Criteria: Gemelli pregnancy (or higher order pregnancy). Known endocrine disorder before pregnancy (diabetes-I, Rheumatoid arthritis). Severe psychiatric disease (schizophrenia, borderline or bipolar disorder). HIV. Drug or alcohol addiction problems. Any other disease resulting in treatment with drugs that are potentially adverse for the fetus and need careful follow-up during pregnancy. No access to the internet.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Other
"Mindful with your Baby" group-based therapist-guided intervention (Intervention group)
"Mindful with your baby" self-guided online intervention (Waitlist control group)
Group-based "Mindful with your Baby" therapist-guided intervention via a video-conferencing tool (e.g., Zoom).
The waitlist control group receives an individual self-guided online "Mindful with your baby" intervention after a 10-week waiting period.